Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03294512 · ClinicalTrials.gov registry record · NA

Pilot and Feasibility Study of a MAWDS (Medications, Activity, Weight, Diet and Symptoms) Heart Failure Mobile Platform

A NA study, sponsored by Intermountain Health Care.

Completed
Registry status
NA
Development phase
15
Enrollment target

NCT03294512 is a NA study that has completed, run by Intermountain Health Care. The registered enrollment target is 15 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03294512, a NA study, has completed, sponsored by Intermountain Health Care.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target

Study Summary

The purpose of this study is to create a smartphone app that delivers the educational content of the current Intermountain MAWDS\* program and allows patients to enter and track their MAWDS data within the app; and to determine if a broad-scale project can be conducted within the limits of currently available technology. Information from this study will be used to design a larger study that is powered to assess the association between data obtained via a MAWDS app and heart failure outcomes. (\*MAWDS- Medications, Activity, Weight, Diet, Symptoms)

Interventions

  • BEHAVIORAL MAWDS data entry on app

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2017-09-28
Est. Completion 2018-05-11
Phase NA

Sponsor

Intermountain Health Care

85 total trials

What the Registry Record Tells You About NCT03294512

The ClinicalTrials.gov registry entry for NCT03294512 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Intermountain Health Care, which has 85 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which MAWDS data entry on app is the first listed.

NCT03294512 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03294512 about?

NCT03294512 is a clinical study titled "Pilot and Feasibility Study of a MAWDS (Medications, Activity, Weight, Diet and Symptoms) Heart Failure Mobile Platform". The purpose of this study is to create a smartphone app that delivers the educational content of the current Intermountain MAWDS\* program and allows patients to enter and track their MAWDS data within the app; and to determine if a broad-scale project can be conducted within the limits of currently...

What is the current status of trial NCT03294512?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2017-09-28. Estimated completion is 2018-05-11.

What interventions are being tested in trial NCT03294512?

The interventions under investigation include: MAWDS data entry on app (BEHAVIORAL).

Who is sponsoring clinical trial NCT03294512?

This trial is sponsored by Intermountain Health Care, which has 85 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.